发明名称 MATRIX METALLOPROTEINASE-INHIBITING 2-OXO-IMIDAZOLIDINE-4- CARBOXYLIC ACID HYDROXAMIDE COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide a 2-oxo-imidazolidine-4-carboxylic acid hydroxisamde derivative, a medicinal composition containing the same derivative and a use of the above derivative in the treatment of arthritis, inflammation, cancer and the other diseases. SOLUTION: This 2-oxo-imidazolidine-4-carboxylic acid hydroxisamde compound is a compound of the formula, wherein, R1 to R4 are each designated in the specification, its pharmaceutically permissible salts and solvated materials, and useful as a matrix metalloproteinase inhibitor. The pharmaceutical composition containing such compound and a method for treating diseases characterized by an inappropriate matrix metalloproteinase activity such as osteo arthritis, chronic rheumatoide arthritis, cancer, osteoporosis, tissue tumorigenesis, restenosis, periodontal disease, inflammation, bolus dermatosis, pleurisy, cerebral stroke, Alzheimer disease, etc., are provided. The method for synthesizing the compound expressed by the formula (1) is also provided.
申请公布号 JP2001261656(A) 申请公布日期 2001.09.26
申请号 JP20010043556 申请日期 2001.02.20
申请人 PFIZER PROD INC 发明人 ELLEN RUTH LYERD;ROBINSON RALPH PELTON JR
分类号 A61K31/4166;A61K31/4174;A61P1/00;A61P1/02;A61P1/04;A61P3/10;A61P7/00;A61P9/04;A61P9/10;A61P9/14;A61P11/00;A61P17/00;A61P17/02;A61P19/02;A61P19/10;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/14;A61P25/16;A61P25/24;A61P25/28;A61P27/02;A61P29/00;A61P31/04;A61P31/18;A61P35/00;A61P37/02;A61P37/08;A61P43/00;C07D233/32;C07D401/06;C07D401/12;C07D491/10;(IPC1-7):C07D233/32;A61K31/416;A61K31/417 主分类号 A61K31/4166
代理机构 代理人
主权项
地址